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Background: The aim of this study was to determine if the post-operative serum arterial lactate concentration is
associated with mortality, length of hospital stay or complications following hepatic resection.
Methods: Serum lactate concentration was recorded at the end of liver resection in a consecutive series of 488
patients over a seven-year period. Liver function, coagulation and electrolyte tests were performed post-operatively.
Renal dysfunction was defined as a creatinine rise of >1.5x the pre-operative value.
Results: The median lactate was 2.8 mmol/L (0.6 to 16 mmol/L) and was elevated (≥2 mmol/L) in 72% of patients.
The lactate concentration was associated with peak post-operative bilirubin, prothrombin time, renal dysfunction,
length of hospital stay and 90-day mortality (P < 0.001). The 90-day mortality in patients with a post-operative
lactate ≥6 mmol/L was 28% compared to 0.7% in those with lactate ≤2 mmol/L. Pre-operative diabetes, number of
segments resected, the surgeon’s assessment of liver parenchyma, blood loss and transfusion were independently
associated with lactate concentration.
Conclusions: Initial post-operative lactate concentration is a useful predictor of outcome following hepatic
resection. Patients with normal post-operative lactate are unlikely to suffer significant hepatic or renal dysfunction
and may not require intensive monitoring or critical care.
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Despite advances in both operative technique and peri-
operative care, liver resection is associated with post-
operative mortality rates of 0% to 22% (median 3.7%)
[1] and morbidity rates of 12.5% to 66% including liver
dysfunction [2,3], renal dysfunction [4] and bile leak [5,6].
Factors associated with peri-operative complications and
death include patient age [7,8] and gender [9,10], hospital
annual number of liver resections undertaken [9,11],
pathologic origin of liver tumour [9,11], pre-operative liver
and renal dysfunction [8,10], diabetes [12,13], chronic liver* Correspondence: david.stell@nhs.net
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reproduction in any medium, provided the ordisease [7,9], and the peripheral neutrophil to lymphocyte
ratio (NLR) [14]. Operative factors associated with
outcome include blood loss [8,10] and transfusion [15,16],
extent of liver resection [15,17], duration of surgery [18],
simultaneous extrahepatic procedures [15,19], and the use
of the Pringle manoeuvre [16,20].
Therefore, many factors affect outcome after liver surgery
which have not been incorporated into a single scoring
system. The American Society of Anesthesiologists (ASA)
grade and Portsmouth Physiologic and Operative Severity
Score for the enUmeration of Mortality and morbidity
(P-POSSUM) scores are used in the risk prediction of
many types of surgery [21,22] including liver surgery
[23]. However, these scores may not be applicable to
the unique stresses of liver resection. One of the main
reported causes of mortality following liver resection is
post-hepatectomy liver failure (PHLF) [24]. Althoughal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and prothrombin index (laboratory’s calculated mean
normal prothrombin time (PT) divided by the patient’s
observed PT) of <50% measured on the fifth post-
operative day have been shown to be associated with
death due to PHLF [2], an earlier prediction system may
be clinically more useful in guiding therapy. Furthermore,
failure of multiple organ systems may contribute to death
following liver resection and there is a need for a global
peri-operative measure to predict the risk of developing
significant post-operative morbidity and death.
Lactic acid is a by-product of anaerobic metabolism
that is subsequently metabolised in the liver during
gluconeogenesis [25]. Hyperlactataemia has been shown
to be associated with increased mortality and morbidity in
a critical care setting [26,27], in patients with liver failure
[28], sepsis [29] and following trauma [30]. Similar re-
lationships have been shown in the post-operative set-
ting following pancreatic resection [31] and other major
abdominal surgery [32], cardiac surgery [33] and after
hepatic transplantation [34].
The primary aim of this study was to determine if the
first post-operative arterial lactate concentration (‘initial
lactate’) is associated with adverse outcomes following
liver resection including 90-day mortality, length of
hospital stay (LOS), and renal and hepatic dysfunction.
The secondary aim was to determine which pre- and
intra-operative risk factors are associated with initial
lactate concentration following liver resection.
Methods
This study was a retrospective analysis of a prospectively
maintained database of all patients undergoing liver
resection since July 2005. Routine patient characteristics,
laboratory data and intra-operative details were retrieved.
Pre-operative liver-directed chemotherapy was adminis-
tered to selected patients following discussion at a regional
multidisciplinary team meeting. A period of recovery
of at least six weeks was allowed following cessation of
chemotherapy before undertaking surgery. The P-POSSUM
scoring system was used to calculate the physiological score
[21]. Prior to resection, the operating surgeon makes a vis-
ual assessment of the condition of the liver parenchyma
and records this as normal or abnormal. Liver resections
were performed using standard techniques with a Cavitron
Ultrasonic Surgical Aspirator™ (CUSA; Tyco Healthcare,
Mansfield, MA, USA) dissector. Hepatic inflow occlusion
was used in a minority of cases where there was excessive
blood loss. Anaesthetic techniques include the routine
use of invasive arterial blood pressure monitoring, central
venous pressure monitoring (CVP) (using a target CVP
of <5 cm H20) and epidural anaesthesia. Liver resections
were defined according to the Brisbane classification
[35] and the number of removed segments recorded.Intravenous fluid replacement was minimised during
the resection phase to decrease venous pressure. After
removal of the surgical specimen, a pause in surgical
activity is routinely planned to allow haemostasis and
intravenous volume replacement with 0.9% saline or
Hartmann’s solution at the anaesthetist’s discretion. Patients
are usually returned to the High Dependency Unit (HDU)
after surgery with full invasive monitoring, except for
minor resections in fit patients who are returned to the
general ward.
The serum lactate was recorded from an arterial blood
sample taken immediately prior to abdominal closure or
immediately on arrival in the HDU. The arterial lactate
in the normal population is below 1.6 mmol/L whereas
in a critical care setting <2 mmol/L is more commonly
accepted in acutely stressed patients [36].
Serum biochemistry tests and coagulation assays were
performed on all patients in the first 24 hours post-
operatively and the tests repeated according to clinical
course. The peak measurement of bilirubin and PT were
recorded and used for analysis. A PT index of <50% corre-
sponds to a PT >24 s. Similarly peak post-operative cre-
atinine levels were obtained and renal dysfunction was
defined according to the Risk, Injury, Failure, Loss, and
End-stage kidney disease (RIFLE) criteria [37]. Renal dys-
function in categorical analyses was defined as any increase
in serum creatinine of ≥1.5-fold from the pre-operative
baseline. The length of hospital stay was measured from
day of surgery to day of discharge and was expressed as a
natural logarithm. Ninety-day mortality was recorded.
The association between initial serum lactate concentra-
tion and continuous outcomes was investigated using a
multiple linear regression model as well as Spearman’s rank
correlation. To overcome increasing variance with the
mean a natural log transformation was used. Binary vari-
ables were investigated using univariate regression. Poten-
tial associations between initial lactate concentration and
pre- and intra-operative factors were tested using univariate
regression or chi-square test at the level of P < 0.25 [38], as
appropriate. Significant variables in the univariate analysis
were included in the multivariate regression model and
were considered to be significant if P < 0.05. All analyses
were carried out using the statistical package R 2.1.14 [39].
Confirmation was obtained from the South West Health
Research Authority that under the harmonised Guidance
Approval for Research Ethics Committees (REC), REC re-
view was not required because patient data was collected
in the course of their normal hospital care and was
anonymised for research purposes. No patient consent
was required for this study.
Results
In the study period 501 patients underwent liver resection
for whom an initial lactate measurement was available in
Table 1 Pre-operative and intra-operative characteristics of 488 patients undergoing liver resection
n = 488 Median (range) Count (%)
Age (years) 65 (21–90)
Gender Female 216 (44.3)
Male 272 (55.7)
Pathology of resected specimen Benign 40 (8.2)
Primary Hepatocellular carcinoma 30 (6.1)
Cholangiocarcinoma 36 (7.4)
Other 35 (7.2)
Secondary Colorectal metastases 291 (59.6)
Other 56 (11.5)
Pre-operative liver-directed chemotherapy Yes 173 (35.5)
No 315 (64.5)
Body mass index 26 (16–54)
P-POSSUM physiologic score 16 (12–32)




Pre-operative diabetes Yes 55 (11.3)
No 433 (88.7)
Pre-operative bilirubin (μmol/L) 9 (2–162)
Pre-operative alkaline phosphatase (U/L) 95 (34–1190)
Pre-operative albumin (g/L) 44 (10–53)
Pre-operative creatinine (μmol/L) 78 (40–430)
Pre-operative glomerular filtration rate (ml/min) ≤90 158 (33.2)
>90 318 (66.8)
Neutrophil to lymphocyte ratio (NLR) 2.47(0.3-17.3)
Operation number 1st 453 (92.8)
2nd 30 (6.1)
3rd 5 (1.0)
Surgeons assessment of liver parenchyma Normal 314 (65.3)
Abnormal 167 (34.7)
Surgical approach Open 440 (90.2)
Laparoscopic 48 (9.8)
Radiofrequency ablation (RFA) included Yes 22 (4.5)
No 466 (95.5)
Operation Right hemihepatectomy 142 (29.1)
Extended right hemihepatectomy 65 (13.3)
Left hemihepatectomy 55 (11.3)
Extended left hemihepatectomy 24 (4.9)
Left lateral sectorectomy 45 (9.2)
Wedge resection only 127 (26.0)
Other 30 (6.1)
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Table 1 Pre-operative and intra-operative characteristics of 488 patients undergoing liver resection (Continued)
Wedge resection included Yes 182 (37.3)
No 306 (62.7)
Bile duct reconstruction included Yes 43 (8.8)
No 445 (91.2)
Synchronous bowel procedure Yes 22 (4.5)
No 466 (95.5)
Curative intent Yes 442 (90.6)
No 46 (9.4)
Number of segments resected 4 (1–6)
Estimated blood loss <100 ml 2 (0.4)
101-500 ml 240 (49.7)
501-1000 ml 167 (34.6)
>1000 ml 74 (15.3)
Units of red cells transfused 0 (0–26)
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tive details are shown in Table 1. Results of blood tests are
shown in Table 2 and the main post-operative outcome
measures are summarised in Table 3. The median number
of biochemistry tests performed per patient in the first five
post-operative days was 4 (0 to 6) and coagulation assays
was 3 (0 to 6). It was not necessary to administer clotting
factors to any surviving patients between postoperative
days 1 to 5. Peak abnormalities in PT and bilirubin usually
occurred early in the post-operative course and tended
to improve over five days (Table 2). Post-operatively,
118 patients (24.1%) had a serum bilirubin ≥50 μmol/L.
Minor abnormalities in PT were commonly noted, though
only 15 patients (3.1%) developed a PT >24 s. Although a
small number of patients remained jaundiced at the time
of discharge, only one patient fulfilled the ‘50-50 criteria’
at day five. The median length of hospital stay was seven
days (range 2 to 78) with 90% of patients having a LOS be-
tween two and 15 days. Twelve patients (2.5%) died within
30 days of surgery and 23 died within 90 days of surgery
(4.7%). The most common cause of death was liver failure,
which occurred in 11 of 23 patients. Four patients died
from ongoing malignancy (of whom three had undergone
non-curative resections) and two patients died from sepsis
without evidence of liver failure. The remaining deathsTable 2 Post-operative blood tests for 488 patients undergoin
n = 488 POD 0 POD 1
Bilirubin Tested (%) 393 (81) 385 (79)
Median (range) 21 (5–170) 27 (6–211)
Prothrombin time Tested (%) 387 (79) 317 (65)
Median (range) 16.3 (12.2-32.4) 18.0 (12–200)
Creatinine Tested (%) 425 (87) 458 (94)
Median (range) 70 (30–319) 70.5 (29–377)were attributed to pulmonary embolus, heart failure, anas-
tomotic leak following colonic resection, bleeding peptic
ulcer, strangulated hernia and peritonitis.
The median initial lactate concentration was 2.8 mmol/
L (inter-quartile range = 1.9 to 3.9) and 350 patients (72%)
had an elevated serum lactate concentration (≥2 mmol/L)
(Figure 1). There was no difference in the lactate concen-
tration taken prior to abdominal closure (n = 380, median
2.8 mmol/L, range 0.6 to 16.0) or immediately on arrival
in the HDU (n = 108, median 2.8 mmol/L, range 0.6 to
14.0). The initial lactate concentration was noted to be
associated with all recorded outcome measures (Table 4).
Although major abnormalities of serum bilirubin and PT
were rare in our series there was a weak correlation with
initial lactate for both bilirubin (coefficient 0.41, P < 0.001)
and PT (coefficient 0.37, P < 0.001), which was stronger for
bilirubin. Similarly, there was a weak correlation with
length of hospital stay (coefficient 0.28, P < 0.001). Of note
the values for length of hospital stay include only survi-
vors, and therefore exclude some patients who are likely
to have high post-operative lactate levels. Renal dys-
function after liver resection was rare in this series
(7.0%) but there was a correlation with lactate concen-
tration (Table 4). Three of 137 patients (2.2%) with an
initial lactate concentration less than 2 mmol/L whog liver resection
POD 2 POD 3 POD 4 POD 5
324 (66) 255 (52) 213 (44) 200 (41)
21 (4–195) 19 (3–167) 18 (4–179) 19 (1–186)
233 (48) 170 (35) 135 (28) 107 (22)
18.0 (12.6-39.4) 16.1 (11.2-37.2) 15.3 (11.6-30.6) 15.4 (12.0-26.4)
374 (77) 288 (59) 241 (49) 226 (46)
64.5 (26–686) 60.5 (28–518) 59 (25–611) 60 (26–292)
Table 3 Post-operative outcomes for 488 patients
undergoing liver resection
n = 488 Median (range) Count (%)
Peak bilirubin (μmol/L) 29 (4–445)
Peak prothrombin time (s) 17.6 (12.4-200)
Length of stay (days) 7 (2–78)










90-day mortality 23 (4.7)
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(negative predictive value (NPV) = 0.98) compared to 8
of 29 (27.5%) patients with an initial lactate greater
than 6 mmol/L (positive predictive value (PPV) = 0.28)
(P = < 0.001) (Figure 2). In 322 patients with a lactate
concentration ≥2 and <6 mmol/L 23 developed renal
dysfunction (7.1%).
Similarly, there was a correlation between mortality in
the 90-day period following liver resection and initial
lactate concentration (Table 4). One of 138 patients (0.7%)
with an initial lactate concentration <2 mmol/L died within
this period, due to an anastomotic leak following colonic
resection (NPV = 0.99), compared to eight of 29 patients
with initial lactate ≥6 mmol/L (PPV = 0.28) (P = < 0.001)
(Figure 3). The deaths in patients with lactate ≥6 mmol/LFigure 1 Distribution of arterial lactate concentration in 488 patientswere due to liver failure in four patients, sepsis without
liver failure in two patients, cardiac failure in one patient
and ongoing malignancy in the other. Of the remaining
322 patients with lactate concentration ≥2 and <6 mmol/L
there were 14 deaths within 90 days of surgery (4.3%).
Comparison of patients with initial lactate concentra-
tions <2 mmol/L and ≥6 mmol/L revealed there were sig-
nificantly more major resections performed (P < 0.001)
and more patients with pre-operative diabetes (P < 0.001)
in patients with a lactate concentration ≥6 mmol/L
(Table 5). There was no significant difference in the use of
pre-operative chemotherapy between these two groups
(P = 0.351). The proportion of patients with both renal
dysfunction and who died within 90 days was significantly
higher in those with lactate concentrations ≥6 mmol/L
(P < 0.001).
Regression analysis revealed that a pre-operative diag-
nosis of diabetes mellitus, the number of liver segments
resected, the operating surgeon’s assessment of the health
of the liver parenchyma, the operative blood loss and num-
ber of units of red cells transfused were all independently
associated with initial lactate concentration at closure
(Table 6). The only pre-operative factor associated with
the post-operative lactate concentration was the presence
of diabetes. On average, this increased the post-operative
lactate concentration at any level by 20% compared to
non-diabetics.
Discussion
The principal findings of this study are that higher ini-
tial serum lactate concentration after liver resection isat the end of liver resection.
Table 4 Univariate analysis of the association between
lactate and postoperative outcomes for 488 patients
undergoing liver resection
n = 488 Co-efficient ± SD P value
Peak bilirubin 0.146 ± 0.017 <0.001*
Peak prothrombin time 0.055 ± 0.002 <0.001*
Length of stay 0.046 ± 0.006 <0.001*
Renal dysfunction 0.324 ± 0.072 <0.001*
90-day mortality 0.373 ± 0.079 <0.001*
*Significant at level of P <0.05.
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and liver dysfunction. Both the 90-day mortality rate
and the rate of renal dysfunction in patients with initial
lactate concentrations greater than 6 mmol/L were 28%
compared to those patients with initial lactate concentra-
tions less than 2 mmol/L where they were 0.7% and 2.2%
respectively. Similarly, higher lactate concentration was
associated with higher post-operative peaks in serum
bilirubin concentration and PT, as well longer lengths of
hospital stay.
These findings support and extend those of an earlier
study [40] by demonstrating the association of post-
operative lactate with renal and hepatic dysfunction
and length of hospital stay in addition to mortality. Pre-
operative diabetes mellitus, the surgeon’s assessment ofFigure 2 Probability of renal dysfunction after liver resection accordinthe liver at laparotomy, the extent of liver resection, blood
loss and the number of units of blood transfused are also
shown to be associated with post-operative serum lactate
concentration.
During cellular hypoxia pyruvate is diverted from the
citric acid cycle and converted to lactate, reducing the
amount of adenosine triphosphate (ATP) generated. This
occurs in all metabolically active tissues including muscle,
gut, liver, brain, erythrocytes and skin [41-43] and is exacer-
bated by intra-operative stresses including blood loss [42],
endogenous release of stress hormones [44] and adminis-
tration of pressor agents [45]. Liver ischaemia induced by
handling of the liver during surgery and temporary inflow
occlusion has been shown to lead to a rise in lactate [46].
Serum lactate can also be increased by transfusion of stored
blood, which contains a higher concentration of lactate
than fresh blood depending on length of storage [47].
Administration of Hartmann’s solution has been shown
to have a small effect on serum lactate concentration
[48]. A potential weakness of this study is that details of
pressor agents were not recorded, which could affect the
lactate concentration. Similarly precise details regarding
intravenous fluid type and volume of fluid (colloid and
crystalloid) were not recorded.
In addition to being a potential source of lactate the
liver is the principle location of lactate metabolism, where
it is converted back to glycogen, accounting for 70% ofg to lactate concentration in 484 patients.
Figure 3 Probability of 90-day mortality after liver resection according to lactate concentration in 488 patients.
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metabolism has been demonstrated following recovery
from partial hepatectomy in either rats [49] or humans
[25], implying that the liver has a large functional reserve
under physiological conditions of lactate production.
However, the effects of intra-operative stress on hepatic
glucose homeostasis have not been assessed, particularly
when in combination with an extended hepatectomy. It
is possible that inflow occlusion during resection and
intra-operative handling of the liver lead to a temporary
impairment of the ability of the liver to metabolise lactate.
The finding of an association between the number of liver
segments resected and the initial post-operative lactate
supports this hypothesis. Diabetes is also known to be asso-
ciated with impaired lactate metabolism via gluconeogenesisTable 5 Distribution of risk factors and outcomes in 138
patients with lactate <2 mmol/L and 29 patients with






Major resection (%) 26 (18.8) 26 (89.7) <0.001*
Pre-operative chemotherapy (%) 38 (27.5) 5 (17.2) 0.351
Pre-operative diabetes (%) 6 (4.3) 8 (27.6) <0.001*
Post-operative renal dysfunction (%) 3 (2.2) 8 (27.6) <0.001*
90-day mortality (%) 1 (0.7) 8 (27.6) <0.001*
*Significant at level of P <0.05.[42] and may account for the strong association with
post-operative lactate in this series. Furthermore, the use
of metformin in non-insulin-dependent diabetes has also
been shown to increase lactate concentration [50]. The
rise in serum lactate at the end of liver resection therefore
may be due to a failure of lactate metabolism in addition
to increased production during surgery.
Significantly, the use of pre-operative chemotherapy was
not shown to be associated with elevation of post-operative
lactate. This may be due to a policy of allowing a period of
recovery after completion of pre-operative chemotherapy
before undertaking surgery. Interestingly, the operating
surgeon’s assessment of the liver parenchyma was associ-
ated with the post-operative lactate concentration. This
finding suggests that patient co-morbidity was a more
common cause of abnormal liver parenchyma than the
use of liver-directed chemotherapy.
An important observation of this study is the relative
rarity of major hepatic dysfunction following liver resection
in this series with only one patient fulfilling the ‘50-50’
criteria [2], who subsequently recovered. Despite the infre-
quency of major disturbances of post-operative bilirubin
and PT, there was an independent association with increas-
ing concentration of post-operative lactate, demonstrating
that even a minor degree of liver injury can lead to im-
paired lactate clearance or increase its production.
Renal dysfunction was also rare in this series, affecting
34 patients (7%) compared to 15% in a similar series
Table 6 Univariate and multivariate analysis of pre- and intra-operative factors associated with serum lactate
concentration following liver resection in 488 patients
N = 488 Univariate analysis Multivariate analysis
Factor P value Co-ef +/− SD P value
Age 0.246* 0.925
Gender 0.012* 0.129
Pathology Benign vs. Primary 0.442 0.144
Primary vs. Secondary 0.226* 0.878
Liver-directed chemotherapy 0.129* 0.219
Open or laparoscopic resection 0.009* 0.611
Radiofrequency ablation 0.191* 0.402
Wedge resection included <0.001* 0.086
Bile duct reconstruction 0.004* 0.651
Number of segments resected <0.001* 0.143 ± 0.012 <0.001†
Synchronous bowel procedure 0.516
Surgeon’s assessment of liver <0.001* 0.185 ± 0.042 <0.001†
Redo operation 1st vs. 2nd resection 0.268
2nd vs. 3rd resection 0.654
Pre-operative diabetes <0.001* 0.204 ± 0.064 0.002†
Body mass index 0.06* 0.905
ASA grade 1 vs. 2 0.014* 0.824
2 vs. 3 0.709 0.872






Pre-operative alkaline phosphatase 0.014* 0.775
Pre-operative creatinine 0.392
Pre-operative glomerular filtration rate (GFR) >90 ml/min 0.042* 0.054
Blood loss (ml) <500 vs. 500-999 <0.001* 0.131 ± 0.038 0.013†
500-999 vs. >1000 0.435 0.884
Units of red cells transfused <0.001* 0.043 ± 0.011 <0.001†
*Significant at the level of 0.25 for univariate analysis and included in multivariate analysis; †significant at the level of 0.05 for multivariate analysis.
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are likely to be similar to those in other forms of abdom-
inal surgery, including blood loss and sepsis, which are
also initiating factors for anaerobic metabolism and lactate
production. This supports the value of initial lactate as an
early predictor of renal dysfunction. Of note, the risk of
renal dysfunction appeared to rise more rapidly when the
post-operative lactate rose above 5 mmol/L (Figure 2).
This suggests that the kidneys are able to tolerate a degree
of oxidative stress to a threshold level beyond which the
risk of damage rises rapidly.
There was a weak association between initial lactate
concentration and length of hospital stay in the study(Table 4). However, this may also be affected by other
factors such as post-operative complications, particularly
bile leaks, and degree of social support.
The strongest association demonstrated was between
lactate concentration and the risk of mortality. In a similar
manner to renal dysfunction, there seems to be a threshold
level of post-operative lactate of approximately 6 mmol/l
above which the risk of 90-day mortality rises rapidly
(Figure 3). Organ dysfunction was a major contributor
to mortality in the series and initial lactate concentration
is a valuable global marker of poor organ function in the
early post-operative period, including cardiovascular, renal
and hepatic dysfunction.
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These findings are of value in clinical practice as it
may be possible to use the initial post-operative lactate
concentration to determine the patient pathway in the
early post-operative period. Patients with an initial post-
operative lactate of less than 2 mmol/L have low rates of
mortality and organ dysfunction and we are currently
evaluating this criterion as a determinant of the need for
post-operative critical care. In addition the correlation of
post-operative lactate with subsequent organ dysfunction
and mortality may allow its use as a single measure of
the impact of innovations in operative technique or
peri-operative care.
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